CoChat

The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials

Open access
Lopez-Huertas, Eduardo · 2012 · British Journal of Nutrition
Cited by 93

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Metabolic syndrome (MS) is characterised by accumulation of CVD risk factors. The use of very long chain n-3 polyunsaturated fatty acids (VLC n 3 PUFA) could potentially benefit MS by reducing risk factors. To better understand the possible VLC n 3 PUFA benefits, the literature was systematically reviewed for randomised controlled trials (RCT) that published effects of VLC n 3 PUFA on MS patients. 17 RCT fulfilled the inclusion criteria and were analysed for relevance to the research question. The available RCT convincingly show that the administration of VLC n 3 PUFA doses > 1 g for at least 3 months produces a significant reduction of triglycerides ranging from 7 % to 25 %. These results confirm the hypotriglyceridemic effect of VLC n 3 PUFA in MS patients. The triglyceride lowering may produce further benefits by reducing the % of pro-atherogenic small dense LDL particles (sdLDL) and also perhaps by ameliorating the inflammatory process associated with MS. High doses of VLC n 3 PUFA ( ≥ 3 g/day) may produce further TAG reductions but could raise other risk factors such as LDL-C. No clear effects were found on other MS markers. The combination of VLC n 3 PUFA plus a statin may be useful to prevent the occurrence of coronary events. More studies are needed using different amounts of VLC n 3 PUFA, time lengths, dietary backgrounds and different profiles of MS patients before clear recommendations can be made.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114512001572

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 93

Metadata

Authors
Lopez-Huertas, E.
Venue
British Journal of Nutrition
Published
2012-05-17
Volume
107
Issue
S2
Pages
S185-S194
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
OpenAlex
W2164928189
Cited by
93
References
22
FWCI
1.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. https://app.cochat.ai/papers/10.1017/s0007114512001572
The paper
Lopez-Huertas, E. (2012). The effect of EPA and DHA on metabolic syndrome patients: a systematic review of randomised controlled trials. British Journal of Nutrition. https://doi.org/10.1017/s0007114512001572

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.